Team Change
Portfolio company Aerska strengthened leadership and board with key appointments to advance RNA medicines for the brain.
Aerska
AerskaAGE1
APR 15, 2026
Essay
Published a guide on the five key decisions between a validated target and a clinical program.
Founder's Playbook: From Target to Development Strategy
FEB 22, 2026
Essay
Published a framework for enabling technologies in longevity biotech and solicited proposals for addressing five key frontiers in the field.
Five Unconquered Frontiers for Longevity biotech: Our 2026 Call for Proposals
FEB 16, 2026
Essay
Published a framework for target validation in drug development before significant capital commitment.
The Cheapest Insurance in Drug Development
FEB 15, 2026